“⚙베스트토토놀이터【평생베스트.com】베스트토토메이저⚙”的搜索结果，显示 91-100 项，共有 2348 项

1. CAR-T 细胞疗法计划- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...

2. 风湿科- 临床试验- 妙佑医疗国际

   The purposes of this study are to explore the therapeutic efficacy of BAFFR-CAR T cells in BAFFR-expressing B-cell hematologic malignancies including large ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... best overall response rate (BORR) of combined ramucirumab (RAM) plus paclitaxel (+/- pembrolizumab) following induction pembrolizumab (PEM) in patients with ...

4. 泌尿科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purposes of this study are to collect prostate surgical samples from metastatic patients to establish xenograft tumor lines for future ...

5. 泌尿科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purposes of this study are to collect prostate surgical samples from metastatic patients to establish xenograft tumor lines for future ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... best overall response rate (BORR) of combined ramucirumab (RAM) plus paclitaxel (+/- pembrolizumab) following induction pembrolizumab (PEM) in patients with ...

7. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn., Scottsdale/Phoenix, Ariz. This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies ...

8. 颅底肿瘤- 症状与病因- 妙佑医疗国际

   Other rare types of benign skull base tumors include craniopharyngiomas, granular cell tumors and angiofibromas. Malignant tumors. Some of the more common types ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... best overall response rate (BORR) of combined ramucirumab (RAM) plus paclitaxel (+/- pembrolizumab) following induction pembrolizumab (PEM) in patients with ...

10. 肺科- 临床试验- 妙佑医疗国际

    The purpose of this study is to evaluate plasma biomarkers of vascular function and inflammation in patients with newly-diagnosed Obstructive Sleep Apnea ...